Mawson Infrastructure Group (OTCMKTS:WIZP) & Dynavax Technologies (NASDAQ:DVAX) Head-To-Head Survey

Mawson Infrastructure Group (OTCMKTS:WIZP) and Dynavax Technologies (NASDAQ:DVAX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.

Profitability

This table compares Mawson Infrastructure Group and Dynavax Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mawson Infrastructure Group	N/A	N/A	-85.32%
Dynavax Technologies	6.88%	2.76%	1.73%

Volatility & Risk

Mawson Infrastructure Group has a beta of 1.77, meaning that its stock price is 77% more volatile than the S&P 500. Comparatively, Dynavax Technologies has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500.

Insider and Institutional Ownership

97.0% of Dynavax Technologies shares are held by institutional investors. 3.0% of Dynavax Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Mawson Infrastructure Group and Dynavax Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mawson Infrastructure Group	N/A	N/A	-$3.45 million	($0.33)	-5.55
Dynavax Technologies	$232.28 million	7.34	-$6.39 million	$0.11	118.28

Mawson Infrastructure Group has higher earnings, but lower revenue than Dynavax Technologies. Mawson Infrastructure Group is trading at a lower price-to-earnings ratio than Dynavax Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Mawson Infrastructure Group and Dynavax Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mawson Infrastructure Group	0	0	0	0	0.00
Dynavax Technologies	0	1	2	0	2.67

Dynavax Technologies has a consensus price target of $22.00, suggesting a potential upside of 69.10%. Given Dynavax Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Dynavax Technologies is more favorable than Mawson Infrastructure Group.

Summary

Dynavax Technologies beats Mawson Infrastructure Group on 11 of the 13 factors compared between the two stocks.

About Mawson Infrastructure Group

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company is headquartered in North Sydney, Australia.

About Dynavax Technologies

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.